Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.22.4
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Assets    
Cash and cash equivalents $ 155,714 $ 226,204
Equity method investments 1,869,712 1,759,651
Receivables 1,990,000  
Receivables held-for-sale 85,254 22,214
Real estate 353,000 356,088
Investments 10,200 17,697
Securitization assets 177,032 210,354
Other assets 119,242 132,165
Total assets 4,760,148 4,148,311
Liabilities:    
Accounts payable, accrued expenses and other 120,114 88,866
Credit facilities 50,698 100,473
Commercial paper notes 192 50,094
Term loan facility 379,742 0
Senior unsecured notes 1,767,647 1,762,763
Convertible notes 344,253 149,731
Total Liabilities 3,095,402 2,581,796
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 90,837,008 and 85,326,781 shares issued and outstanding, respectively 908 853
Additional paid in capital 1,924,200 1,727,667
Accumulated deficit (285,474) (193,706)
Accumulated other comprehensive income (loss) (10,397) 9,904
Non-controlling interest 35,509 21,797
Total Stockholders’ Equity 1,664,746 1,566,515
Total Liabilities and Stockholders’ Equity 4,760,148 4,148,311
Non-recourse    
Liabilities:    
Non-recourse debt (secured by assets of $632 million and $573 million, respectively) 432,756 429,869
Commercial receivables    
Assets    
Receivables 1,887,483 1,298,529
Government receivables    
Assets    
Receivables $ 102,511 $ 125,409